CytoMed Therapeutics Limited Share Price
Equities
GDTC
SGXZ17669631
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.067 USD | +2.34% | -2.95% | -57.81% |
Sales 2024 * | 520K 40.83M | Sales 2025 * | 520K 40.83M | Capitalization | 23.31M 1.83B |
---|---|---|---|---|---|
Net income 2024 * | -1M -78.52M | Net income 2025 * | -1M -78.52M | EV / Sales 2024 * | 36.4 x |
Net cash position 2024 * | 4.36M 342M | Net cash position 2025 * | 2.33M 183M | EV / Sales 2025 * | 40.4 x |
P/E ratio 2024 * |
-10.3
x | P/E ratio 2025 * |
-10.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 29.3% |
1 day | +2.34% | ||
1 week | -2.95% | ||
Current month | -2.03% | ||
1 month | -3.85% | ||
3 months | -6.04% | ||
6 months | -44.13% | ||
Current year | -57.81% |
Managers | Title | Age | Since |
---|---|---|---|
Wee Kiat Tan
CEO | Chief Executive Officer | 36 | 31/01/19 |
Yvonne Goh
DFI | Director of Finance/CFO | 35 | 29/02/20 |
Jieming Zeng
CTO | Chief Tech/Sci/R&D Officer | 51 | 31/07/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chee Kong Choo
FOU | Founder | 65 | 08/03/18 |
Tao Wu
BRD | Director/Board Member | 59 | 17/04/23 |
Kei Wei Leong
BRD | Director/Board Member | 49 | 17/04/23 |
Date | Price | Change | Volume |
---|---|---|---|
24/05/24 | 2.067 | +2.34% | 1,608 |
23/05/24 | 2.02 | -1.94% | 825 |
22/05/24 | 2.06 | +0.98% | 651 |
21/05/24 | 2.04 | +0.49% | 3,672 |
20/05/24 | 2.03 | -4.25% | 3,963 |
Delayed Quote Nasdaq, May 24, 2024 at 09:30 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.81% | 23.31M | |
+12.30% | 116B | |
+12.15% | 106B | |
-8.14% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-15.33% | 16.33B | |
+5.80% | 14.14B | |
+28.03% | 12.02B |
- Stock Market
- Equities
- GDTC Stock